var data={"title":"Approach to the patient with retiform (angulated) purpura","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Approach to the patient with retiform (angulated) purpura</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/contributors\" class=\"contributor contributor_credentials\">Robert Kelly, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/contributors\" class=\"contributor contributor_credentials\">Erik Stratman, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/contributors\" class=\"contributor contributor_credentials\">Abena O Ofori, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Nov 30, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H429795\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Purpura are nonblanchable, hemorrhagic skin lesions that result from the leakage of red blood cells into the skin. The term &quot;retiform purpura&quot; describes lesions that demonstrate an angulated or branched configuration (<a href=\"image.htm?imageKey=DERM%2F53920%7EDERM%2F61719%7EDERM%2F65011\" class=\"graphic graphic_picture graphicRef53920 graphicRef61719 graphicRef65011 \">picture 1A-C</a>). Retiform purpura can occur in a variety of disorders; thus, identifying the underlying cause is an important component of patient management.</p><p>The potential causes of retiform purpura and the approach to the assessment of patients with these lesions will be reviewed here. Additional details on the pathogenesis, clinical manifestations, and treatment of disorders that present with retiform purpura are discussed elsewhere in UpToDate. (See <a href=\"#H425705\" class=\"local\">'Associated disorders'</a> below.)</p><p class=\"headingAnchor\" id=\"H425698\"><span class=\"h1\">ETIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Retiform purpura develop as a consequence of complete vascular occlusion and vascular damage involving blood vessels in the skin. As in livedo reticularis (<a href=\"image.htm?imageKey=DERM%2F79545%7EDERM%2F61842\" class=\"graphic graphic_picture graphicRef79545 graphicRef61842 \">picture 2A-B</a>) and livedo racemosa (<a href=\"image.htm?imageKey=DERM%2F64023\" class=\"graphic graphic_picture graphicRef64023 \">picture 3</a>) (additional disorders associated with vasculopathy or vasculitis), the angulated or branched shape of retiform purpura reflects the vascular architecture in the skin (see <a href=\"#H249255\" class=\"local\">'Differential diagnosis'</a> below). The hemorrhagic appearance of purpura results from the local extravasation of red blood cells. Often, skin necrosis due to infarction is present.</p><p class=\"headingAnchor\" id=\"H425705\"><span class=\"h2\">Associated disorders</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Multiple noninflammatory and inflammatory vasculopathic disorders may present with retiform purpura. Lesions may occur in the setting of intravascular abnormalities in which thrombi, proteins, or emboli obstruct cutaneous vessels, or may involve direct damage to vessel walls, as occurs in vasculitis, calciphylaxis, and some severe opportunistic infections. </p><p class=\"headingAnchor\" id=\"H933744\"><span class=\"h3\">Intravascular abnormalities</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>As noted above, thrombosis, intravascular deposition of abnormal proteins, and embolic phenomena may result in the development of retiform purpura.</p><p class=\"headingAnchor\" id=\"H933761\"><span class=\"h4\">Thrombotic and coagulopathic disorders</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Disseminated intravascular coagulation (DIC) </strong>&ndash; DIC may occur in the setting of sepsis, organ failure, trauma, malignancy, and other severe disorders, such as homozygous C deficiency in neonates. Patients with DIC exhibit clinical manifestations of both hemorrhage and thrombosis. Purpura may be widespread (<strong>purpura fulminans</strong>), and the disorder can be fatal<strong> </strong>(<a href=\"image.htm?imageKey=DERM%2F61719%7EDERM%2F74453\" class=\"graphic graphic_picture graphicRef61719 graphicRef74453 \">picture 1B, 1D</a>) [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/1,2\" class=\"abstract_t\">1,2</a>]. Meningococcemia is a common cause of DIC. (See <a href=\"#H136707379\" class=\"local\">'Life-threatening emergency (purpura fulminans)'</a> below and <a href=\"topic.htm?path=clinical-features-diagnosis-and-treatment-of-disseminated-intravascular-coagulation-in-adults\" class=\"medical medical_review\">&quot;Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults&quot;</a> and <a href=\"topic.htm?path=disseminated-intravascular-coagulation-in-infants-and-children\" class=\"medical medical_review\">&quot;Disseminated intravascular coagulation in infants and children&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Antiphospholipid syndrome </strong>&ndash; The mechanisms through which antiphospholipid antibodies in serum lead to thrombosis are not completely understood (<a href=\"image.htm?imageKey=DERM%2F65011%7EDERM%2F65890\" class=\"graphic graphic_picture graphicRef65011 graphicRef65890 \">picture 1C, 1E</a>). Common additional features of this disorder include livedo reticularis, cutaneous infarctions or ulceration, recurrent venous or arterial thromboses, and fetal loss [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/3-6\" class=\"abstract_t\">3-6</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-of-antiphospholipid-syndrome\" class=\"medical medical_review\">&quot;Clinical manifestations of antiphospholipid syndrome&quot;</a> and <a href=\"topic.htm?path=diagnosis-of-antiphospholipid-syndrome\" class=\"medical medical_review\">&quot;Diagnosis of antiphospholipid syndrome&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Thrombotic thrombocytopenic purpura (TTP) </strong>&ndash; TTP is a rare idiopathic disorder characterized by microangiopathic hemolytic anemia, thrombocytopenia, neurologic abnormalities, and renal disease [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/7,8\" class=\"abstract_t\">7,8</a>]. Non-retiform purpura related to thrombocytopenia are often present. (See <a href=\"topic.htm?path=acquired-ttp-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Acquired TTP: Clinical manifestations and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Warfarin-induced skin necrosis </strong>&ndash; This condition results from the development of a transient hypercoagulable state secondary to warfarin-induced reduction of protein C (an anticoagulant) early in the course of <a href=\"topic.htm?path=warfarin-drug-information\" class=\"drug drug_general\">warfarin</a> therapy. Purpura are extensive and demonstrate a predilection for areas with significant adipose tissue (eg, thighs, buttocks, abdomen, breasts) (<a href=\"image.htm?imageKey=DERM%2F51999%7EDERM%2F62792%7EHEME%2F80462\" class=\"graphic graphic_picture graphicRef51999 graphicRef62792 graphicRef80462 \">picture 4A-C</a>). Patients with underlying protein C deficiency are at increased risk for this disorder [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/9-11\" class=\"abstract_t\">9-11</a>]. (See <a href=\"topic.htm?path=protein-c-deficiency#H13\" class=\"medical medical_review\">&quot;Protein C deficiency&quot;, section on 'Warfarin-induced skin necrosis'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Heparin-induced thrombocytopenia </strong>&ndash;<strong> </strong>Heparin&ndash;induced thrombocytopenia is an immune-mediated disorder that usually occurs 5 to 10 days after treatment with heparin [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/12,13\" class=\"abstract_t\">12,13</a>]. Necrotic, purpuric lesions may occur at sites of subcutaneous heparin injection or in areas distant from the site of administration (heparin necrosis). Patients may also exhibit large vessel venous or arterial thromboses<strong> </strong>[<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/12,13\" class=\"abstract_t\">12,13</a>]<strong> </strong>(see <a href=\"topic.htm?path=management-of-heparin-induced-thrombocytopenia\" class=\"medical medical_review\">&quot;Management of heparin-induced thrombocytopenia&quot;</a>). Heparin necrosis may also occur in the absence of thrombocytopenia (<a href=\"image.htm?imageKey=DERM%2F63715%7EDERM%2F71259\" class=\"graphic graphic_picture graphicRef63715 graphicRef71259 \">picture 5A-B</a>).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Paroxysmal nocturnal hemoglobinuria </strong>&ndash; This rare disorder due to a defect in the PIG-A gene is characterized by venous thrombosis and hemolysis resulting in hemoglobinuria. In addition to retiform purpura, patients may present with bullae, petechiae, or ulcerations. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-paroxysmal-nocturnal-hemoglobinuria\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of paroxysmal nocturnal hemoglobinuria&quot;</a> and <a href=\"topic.htm?path=treatment-and-prognosis-of-paroxysmal-nocturnal-hemoglobinuria\" class=\"medical medical_review\">&quot;Treatment and prognosis of paroxysmal nocturnal hemoglobinuria&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H933953\"><span class=\"h4\">Intravascular protein deposition</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Cryoglobulinemia (type I) </strong>&ndash; In type 1 cryoglobulinemia, retiform purpura develop in the setting of blood hyperviscosity and blood vessel occlusion due to the precipitation of immunoglobulins in response to cold. Lesions are often found on acral areas; livedo reticularis, acrocyanosis, and infarction may also be present [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/14,15\" class=\"abstract_t\">14,15</a>]. (See <a href=\"topic.htm?path=overview-of-cryoglobulins-and-cryoglobulinemia\" class=\"medical medical_review\">&quot;Overview of cryoglobulins and cryoglobulinemia&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Cryofibrinogenemia </strong>&ndash; Cryofibrinogenemia results from the precipitation of fibrin, fibrinogen, <span class=\"nowrap\">and/or</span> fibronectin in plasma during cold exposure. Like cryoglobulinemia, retiform purpura are often acral. Additional findings may include livedo reticularis and painful ulcerations [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/16\" class=\"abstract_t\">16</a>]. (See <a href=\"topic.htm?path=cryofibrinogenemia\" class=\"medical medical_review\">&quot;Cryofibrinogenemia&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Paraproteinemia </strong>&ndash; Rarely, paraproteinemia induces blood hyperviscosity and plugging of vessels, resulting in the development of retiform purpura [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/17\" class=\"abstract_t\">17</a>].</p><p/><p class=\"headingAnchor\" id=\"H933961\"><span class=\"h4\">Embolic disorders</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Cholesterol emboli </strong>&ndash; Retiform purpura associated with cholesterol embolization are often located on the distal lower extremities (<a href=\"image.htm?imageKey=DERM%2F69150\" class=\"graphic graphic_picture graphicRef69150 \">picture 6</a>). Other cutaneous features include livedo reticularis, gangrene, cutaneous infarction, ulceration, and cyanosis (blue toe syndrome). Renal, gastrointestinal, ocular, or central nervous system abnormalities may also occur. Many patients exhibit eosinophilia [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/18,19\" class=\"abstract_t\">18,19</a>]. (See <a href=\"topic.htm?path=embolism-from-atherosclerotic-plaque-atheroembolism-cholesterol-crystal-embolism\" class=\"medical medical_review\">&quot;Embolism from atherosclerotic plaque: Atheroembolism (cholesterol crystal embolism)&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Septic emboli </strong>&ndash; Purpura due to septic emboli most commonly occur in the setting of infectious endocarditis, but may also occur in other forms of septicemia. Lesions typically are acral. Other cutaneous findings, such as petechiae or Janeway lesions, may be present. (See <a href=\"topic.htm?path=clinical-manifestations-and-evaluation-of-adults-with-suspected-native-valve-endocarditis\" class=\"medical medical_review\">&quot;Clinical manifestations and evaluation of adults with suspected native valve endocarditis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Atrial myxoma </strong>&ndash; Atrial myxomas are benign tumors of the heart. Tumor fragments may embolize systemically and patients often exhibit constitutional symptoms (eg, fever, weight loss) [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/20,21\" class=\"abstract_t\">20,21</a>]. As with other embolic phenomena, lesions are often acral. (See <a href=\"topic.htm?path=cardiac-tumors#H14\" class=\"medical medical_review\">&quot;Cardiac tumors&quot;, section on 'Myxomas'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Other </strong>&ndash;<strong> </strong>Emboli resulting in vessel occlusion and retiform purpura may also occur in nonbacterial thrombotic endocarditis (marantic endocarditis, Libman-Sacks endocarditis) and hypereosinophilic syndrome.</p><p/><p class=\"headingAnchor\" id=\"H933969\"><span class=\"h3\">Vessel wall pathology</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Vasculitis </strong>&ndash; Vasculitis is defined by the presence of an inflammatory infiltrate invading blood vessel walls and fibrinoid necrosis (fibrin deposition within vessel walls or lumina). Retiform purpura are classically seen in vasculitides that affect medium-sized cutaneous vessels. In contrast, small vessel vasculitis most often presents with non-retiform palpable purpura. (See <a href=\"topic.htm?path=evaluation-of-adults-with-cutaneous-lesions-of-vasculitis#H606549\" class=\"medical medical_review\">&quot;Evaluation of adults with cutaneous lesions of vasculitis&quot;, section on 'Diagnostic criteria'</a> and <a href=\"topic.htm?path=evaluation-of-adults-with-cutaneous-lesions-of-vasculitis#H1117785\" class=\"medical medical_review\">&quot;Evaluation of adults with cutaneous lesions of vasculitis&quot;, section on 'Etiology'</a>.)</p><p/><p class=\"bulletIndent1\">Examples of vasculitides that may present with retiform purpura include:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Septic vasculitis </strong>&ndash; Vasculitis presenting with retiform purpura may occur in meningococcemia, gonococcemia, pseudomonal or streptococcal septicemia, rickettsial infections, infective endocarditis, and other infectious states [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/22-24\" class=\"abstract_t\">22-24</a>]. In the setting of severe infection, retiform purpura may also result from disseminated intravascular coagulation (DIC). (See <a href=\"topic.htm?path=clinical-manifestations-of-meningococcal-infection\" class=\"medical medical_review\">&quot;Clinical manifestations of meningococcal infection&quot;</a> and <a href=\"#H136707379\" class=\"local\">'Life-threatening emergency (purpura fulminans)'</a> below.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Vasculitis related to autoimmune disease or primary systemic vasculitis </strong>(eg, rheumatoid arthritis, systemic lupus erythematosus, cutaneous or systemic polyarteritis nodosa, granulomatosis with polyangiitis [formerly known as Wegener's granulomatosis], eosinophilic granulomatosis with polyangiitis [Churg-Strauss]). (See <a href=\"topic.htm?path=evaluation-of-adults-with-cutaneous-lesions-of-vasculitis#H1117785\" class=\"medical medical_review\">&quot;Evaluation of adults with cutaneous lesions of vasculitis&quot;, section on 'Etiology'</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Cryoglobulinemic vasculitis (cryoglobulinemia types 2 and 3)</strong> [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/14,25\" class=\"abstract_t\">14,25</a>]. (See <a href=\"topic.htm?path=overview-of-cryoglobulins-and-cryoglobulinemia\" class=\"medical medical_review\">&quot;Overview of cryoglobulins and cryoglobulinemia&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-the-mixed-cryoglobulinemia-syndrome-essential-mixed-cryoglobulinemia\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of the mixed cryoglobulinemia syndrome (essential mixed cryoglobulinemia)&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Opportunistic infections </strong>&ndash;<strong> </strong>In immunocompromised patients, invasion of infectious organisms into blood vessel walls and lumina may result in vessel occlusion and the development of retiform purpura. This phenomenon may be seen in association with pseudomonal infection (ecthyma gangrenosum (<a href=\"image.htm?imageKey=DERM%2F53544\" class=\"graphic graphic_picture graphicRef53544 \">picture 7</a>)), invasive fungal infections (eg, mucormycosis, aspergillosis, candidiasis), disseminated strongyloidiasis, and in lepromatous leprosy as a feature of the Lucio phenomenon. (See <a href=\"topic.htm?path=mucormycosis-zygomycosis\" class=\"medical medical_review\">&quot;Mucormycosis (zygomycosis)&quot;</a> and <a href=\"topic.htm?path=epidemiology-and-clinical-manifestations-of-invasive-aspergillosis\" class=\"medical medical_review\">&quot;Epidemiology and clinical manifestations of invasive aspergillosis&quot;</a> and <a href=\"topic.htm?path=strongyloidiasis\" class=\"medical medical_review\">&quot;Strongyloidiasis&quot;</a> and <a href=\"topic.htm?path=epidemiology-microbiology-clinical-manifestations-and-diagnosis-of-leprosy#H2780058\" class=\"medical medical_review\">&quot;Epidemiology, microbiology, clinical manifestations, and diagnosis of leprosy&quot;, section on 'Type 2 reaction'</a> and <a href=\"topic.htm?path=pseudomonas-aeruginosa-bacteremia-and-endocarditis#H4\" class=\"medical medical_review\">&quot;Pseudomonas aeruginosa bacteremia and endocarditis&quot;, section on 'Clinical features'</a> and <a href=\"topic.htm?path=pseudomonas-aeruginosa-skin-and-soft-tissue-infections#H1133434152\" class=\"medical medical_review\">&quot;Pseudomonas aeruginosa skin and soft tissue infections&quot;, section on 'Ecthyma Gangrenosum'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Calciphylaxis </strong>(<a href=\"image.htm?imageKey=DERM%2F66308\" class=\"graphic graphic_picture graphicRef66308 \">picture 8</a>)<strong> </strong>&ndash; Calciphylaxis is a <strong>life-threatening disorder</strong> characterized by the deposition of calcium in blood vessels. This condition almost always occurs in the setting of advanced chronic renal failure. Extremely painful retiform purpura may develop; lesions frequently occur in adipose-rich areas, such as the buttocks, abdomen, or thighs. Other cutaneous features include livedo reticularis and cutaneous infarction [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/26,27\" class=\"abstract_t\">26,27</a>]. (See <a href=\"topic.htm?path=calciphylaxis-calcific-uremic-arteriolopathy\" class=\"medical medical_review\">&quot;Calciphylaxis (calcific uremic arteriolopathy)&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Primary hyperoxaluria </strong>&ndash; Primary hyperoxaluria is a rare, autosomal recessive metabolic disorder that results in the overproduction of oxalate. Patients develop renal stones and calcium oxalate deposits in multiple tissues, including blood vessels [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/28,29\" class=\"abstract_t\">28,29</a>]. The cutaneous lesions of primary hyperoxaluria are similar to calciphylaxis. (See <a href=\"topic.htm?path=primary-hyperoxaluria\" class=\"medical medical_review\">&quot;Primary hyperoxaluria&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H8555196\"><span class=\"h3\">Other</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Livedoid vasculopathy </strong>&ndash;<strong> </strong>Livedoid vasculopathy (also known as atrophie blanche) is a cutaneous disease characterized by the development of fibrin thrombi in cutaneous vessels. The condition typically manifests as recurrent, small, purpuric, ulcerative lesions on the distal lower extremities (<a href=\"image.htm?imageKey=DERM%2F52262\" class=\"graphic graphic_picture graphicRef52262 \">picture 9</a>). Pale scars with stippled telangiectasia are left after healing [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/30-32\" class=\"abstract_t\">30-32</a>]. (See <a href=\"topic.htm?path=livedoid-vasculopathy\" class=\"medical medical_review\">&quot;Livedoid vasculopathy&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Pyoderma gangrenosum </strong>&ndash; Pyoderma gangrenosum is an inflammatory skin disorder that typically presents with ulceration. Infrequently, it may present with retiform purpura that evolve into ulcers that exhibit the violaceous edges classically seen in this disorder. Pyoderma gangrenosum may occur in association with inflammatory bowel disease, inflammatory arthritis, or hematologic malignancies [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/33-35\" class=\"abstract_t\">33-35</a>]. (See <a href=\"topic.htm?path=pyoderma-gangrenosum-pathogenesis-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Pyoderma gangrenosum: Pathogenesis, clinical features, and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Thrombotic vasculopathy or vasculitis due to levamisole-contaminated cocaine </strong>&ndash;<strong> </strong>Use of cocaine contaminated with levamisole has been associated with the development of tender purpura on the ears and necrotic, retiform purpura on the trunk or extremities (<a href=\"image.htm?imageKey=DERM%2F74436%7EDERM%2F77067%7EDERM%2F55590\" class=\"graphic graphic_picture graphicRef74436 graphicRef77067 graphicRef55590 \">picture 10A-C</a>). (See <a href=\"topic.htm?path=evaluation-of-adults-with-cutaneous-lesions-of-vasculitis#H810822\" class=\"medical medical_review\">&quot;Evaluation of adults with cutaneous lesions of vasculitis&quot;, section on 'Evaluation for vasculitis due to levamisole-contaminated cocaine'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H425712\"><span class=\"h1\">PATIENT ASSESSMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The first step in the assessment of patients with retiform purpura is to exclude acute life-threatening disease. After that, a thorough history and physical examination can provide valuable clues for diagnosis.</p><p class=\"headingAnchor\" id=\"H136707379\"><span class=\"h2\">Life-threatening emergency (purpura fulminans)</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acute, widespread retiform purpura, also known as purpura fulminans, can occur in the setting of acute disseminated intravascular coagulation (DIC) due to sepsis, trauma, malignancy, obstetric emergencies, neonatal homozygous C deficiency, and other causes (<a href=\"image.htm?imageKey=DERM%2F57103%7EDERM%2F53920%7EID%2F52107\" class=\"graphic graphic_picture graphicRef57103 graphicRef53920 graphicRef52107 \">picture 1A, 1F-G</a>). Patients with purpura fulminans are often acutely ill, and frequently have signs or symptoms of shock. A diagnosis of DIC can be confirmed with serologic tests. (See <a href=\"topic.htm?path=clinical-features-diagnosis-and-treatment-of-disseminated-intravascular-coagulation-in-adults#H12\" class=\"medical medical_review\">&quot;Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults&quot;, section on 'Diagnostic evaluation'</a> and <a href=\"topic.htm?path=disseminated-intravascular-coagulation-in-infants-and-children#H20\" class=\"medical medical_review\">&quot;Disseminated intravascular coagulation in infants and children&quot;, section on 'Diagnosis'</a>.)</p><p>Mortality from acute DIC is high, and early management and identification of the underlying cause is essential. Sepsis is a common cause of DIC, and obtaining of blood, urine, and skin biopsy tissue cultures is appropriate. The treatment of DIC is discussed elsewhere. (See <a href=\"topic.htm?path=clinical-features-diagnosis-and-treatment-of-disseminated-intravascular-coagulation-in-adults#H25\" class=\"medical medical_review\">&quot;Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults&quot;, section on 'Treatment'</a> and <a href=\"topic.htm?path=disseminated-intravascular-coagulation-in-infants-and-children#H29\" class=\"medical medical_review\">&quot;Disseminated intravascular coagulation in infants and children&quot;, section on 'Treatment'</a>.)</p><p>The possibility of life-threatening infections in the absence of DIC should also be considered in patients with retiform purpura, particularly in immunocompromised patients. (See <a href=\"#H933969\" class=\"local\">'Vessel wall pathology'</a> above.)</p><p class=\"headingAnchor\" id=\"H425719\"><span class=\"h2\">Patient history</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The medical history should be obtained with particular emphasis on factors that may assist with the identification of the underlying disorder, such as:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Symptoms of infection</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>History of thrombotic disease, which may suggest antiphospholipid syndrome or genetic disorders characterized by hypercoagulability</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Deep venous thromboses or pulmonary emboli</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Recurrent spontaneous abortions</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Family history of thrombotic events</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Drug history, which may suggest warfarin-induced skin necrosis, heparin-induced thrombocytopenia, or vasculopathy or vasculitis due to levamisole-contaminated cocaine</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>History of organ dysfunction</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Renal failure, which may suggest calciphylaxis</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>History of heart murmur or valve dysfunction, which may suggest endocarditis or atrial myxoma</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>History of myeloproliferative conditions and blood dyscrasias, which may suggest occlusion related to blood hyperviscosity</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>History of hyperlipidemia, ischemic heart disease, or peripheral vascular disease, which may suggest atheroemboli</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>History of or symptoms of connective tissue disease or primary systemic vasculitis, which may suggest vasculitis related to rheumatoid arthritis, systemic lupus erythematosus, polyarteritis nodosa, granulomatosis with polyangiitis (formerly known as Wegener's granulomatosis), or eosinophilic granulomatosis with polyangiitis (EGPA, Churg-Strauss)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Exacerbation of lesions with cold exposure, which may suggest cryoglobulinemia or cryofibrinogenemia</p><p/><p class=\"headingAnchor\" id=\"H425726\"><span class=\"h2\">Physical examination</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A full physical examination should be performed. The skin examination should include an assessment of the appearance, palpability, and distribution of purpuric lesions, as well as the presence of other cutaneous findings. </p><p class=\"headingAnchor\" id=\"H428237\"><span class=\"h3\">Lesion color and palpability</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Retiform purpura are typically dark red to dark purple in color, and unlike erythema associated with nonpurpuric inflammatory skin disorders, the color of purpura fails to blanch under pressure. Diascopy (application of pressure to a lesion with a glass slide) can be used to confirm the nonblanchable nature of a purpuric lesion. With time and the breakdown of extravasated hemoglobin, purpura may develop a greenish or yellow-brown coloration.</p><p>In some cases, early lesions demonstrate significant erythema, which suggests the presence of a primary inflammatory process [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/36\" class=\"abstract_t\">36</a>]. These inflammatory lesions are frequently palpable, and may appear in the following conditions:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Vasculitis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Livedoid vasculopathy</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Chilblains</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pyoderma gangrenosum</p><p/><p>Retiform purpura associated with noninflammatory intravascular occlusive vasculopathies may be palpable or macular, but typically lack prominent erythema. (See <a href=\"#H933744\" class=\"local\">'Intravascular abnormalities'</a> above.)</p><p>Areas of necrosis due to tissue infarction may occur in both noninflammatory and inflammatory lesions.</p><p class=\"headingAnchor\" id=\"H428245\"><span class=\"h3\">Lesion distribution</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The clinical distribution of lesions may assist in diagnosis. As examples:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Retiform purpura in areas with significant adipose tissue, such as the buttocks, thighs, and abdomen may occur in warfarin-induced skin necrosis or calciphylaxis.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Retiform purpura predominantly involving lower extremities may occur in vasculitis, livedoid vasculopathy, cholesterol emboli, or calciphylaxis. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Retiform purpura primarily involving acral areas may occur in septic vasculitis, embolic disorders, cryoglobulinemia, or cryofibrinogenemia.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Widespread, extensive purpura (purpura fulminans) may occur in disseminated intravascular coagulation or warfarin-induced skin necrosis. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The presence of unilateral lesions may suggest embolic phenomena.</p><p/><p class=\"headingAnchor\" id=\"H249255\"><span class=\"h3\">Differential diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Retiform purpura must be distinguished from livedo reticularis and livedo racemosa, both of which are nonpurpuric disorders that present with accentuated vascular patterns in the skin. Livedo reticularis, which results from the slowing of blood flow through cutaneous vessels, presents as a blanchable, patchy, reticulated vascular pattern with a red-blue or violaceous hue (<a href=\"image.htm?imageKey=DERM%2F79545%7EDERM%2F61842\" class=\"graphic graphic_picture graphicRef79545 graphicRef61842 \">picture 2A-B</a>). Livedo racemosa, which develops in the setting of irregular impairment of blood flow, is characterized by a more abrupt and broken vascular pattern with or without areas of necrosis (<a href=\"image.htm?imageKey=DERM%2F64023\" class=\"graphic graphic_picture graphicRef64023 \">picture 3</a>). In some conditions, retiform purpura may coexist with livedo reticularis or livedo racemosa. (See <a href=\"#H425705\" class=\"local\">'Associated disorders'</a> above and <a href=\"topic.htm?path=evaluation-of-adults-with-cutaneous-lesions-of-vasculitis#H606666\" class=\"medical medical_review\">&quot;Evaluation of adults with cutaneous lesions of vasculitis&quot;, section on 'Common features'</a>.)</p><p>Retiform purpura must also be distinguished from petechiae or purpura due to trauma or bleeding diatheses, which typically lack the angulated shape of retiform lesions (<a href=\"image.htm?imageKey=DERM%2F76671%7EDERM%2F70793\" class=\"graphic graphic_picture graphicRef76671 graphicRef70793 \">picture 11A-B</a>). </p><p class=\"headingAnchor\" id=\"H428253\"><span class=\"h3\">Associated physical findings</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The presence of additional cutaneous or extracutaneous findings should be assessed. As examples, the detection of a heart murmur, splinter hemorrhages (<a href=\"image.htm?imageKey=ID%2F72076\" class=\"graphic graphic_picture graphicRef72076 \">picture 12</a>), Osler nodes (<a href=\"image.htm?imageKey=ID%2F68796\" class=\"graphic graphic_picture graphicRef68796 \">picture 13</a>), or Janeway lesions (<a href=\"image.htm?imageKey=ID%2F58380\" class=\"graphic graphic_picture graphicRef58380 \">picture 14</a>) suggests infectious endocarditis, and respiratory symptoms may occur in patients with EGPA or granulomatosis with polyangiitis (Wegener's granulomatosis).</p><p>The detection of additional cutaneous findings may also assist with diagnosis. As an example, livedo reticularis (<a href=\"image.htm?imageKey=DERM%2F79545%7EDERM%2F61842\" class=\"graphic graphic_picture graphicRef79545 graphicRef61842 \">picture 2A-B</a>) is a common feature of several disorders that may present with retiform purpura, such as antiphospholipid antibody syndrome, polyarteritis nodosa, cholesterol emboli, and cryoglobulinemia.</p><p class=\"headingAnchor\" id=\"H426722\"><span class=\"h2\">Skin biopsy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Skin biopsies offer insight into the pathogenic mechanism of retiform purpura, and therefore, can be useful for diagnosis. We advocate the use of skin biopsies in most patients.</p><p class=\"headingAnchor\" id=\"H428261\"><span class=\"h3\">Type and location of biopsy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Evaluation of vessels in the dermis and subcutis is important in retiform purpura. Thus, punch or incisional wedge biopsies are performed, rather than more superficial shave biopsies. Preferred sites for biopsies include areas that are painful or tender; biopsying both from the center and the edge of a lesion may also increase the diagnostic yield [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/37\" class=\"abstract_t\">37</a>]. Areas of frank necrosis or ulceration should be <strong>avoided</strong>, since necrotic tissue may fail to demonstrate diagnostic histopathologic findings. In addition, biopsies of necrotic areas may demonstrate an inflammatory response resembling primary vasculitis in patients with nonvasculitic disorders [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/36\" class=\"abstract_t\">36</a>]. </p><p>When infection is suspected, a tissue specimen should also be sent for culture. As mentioned above, vasculitis is a common cause of inflammatory retiform purpura. The approach to the biopsy of lesions that are suspicious for vasculitis is reviewed separately. (See <a href=\"topic.htm?path=evaluation-of-adults-with-cutaneous-lesions-of-vasculitis#H16171991\" class=\"medical medical_review\">&quot;Evaluation of adults with cutaneous lesions of vasculitis&quot;, section on 'Biopsy'</a>.)</p><p class=\"headingAnchor\" id=\"H428268\"><span class=\"h3\">Assessment of biopsy results</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Several histopathologic patterns are associated with retiform purpura; a table correlating histopathologic findings with specific disorders is provided (<a href=\"image.htm?imageKey=DERM%2F77042\" class=\"graphic graphic_table graphicRef77042 \">table 1</a>).</p><p class=\"headingAnchor\" id=\"H426729\"><span class=\"h2\">Laboratory tests</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Appropriate initial laboratory studies for the stable patient with noninflammatory retiform purpura include (see <a href=\"#H933744\" class=\"local\">'Intravascular abnormalities'</a> above) [<a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/36\" class=\"abstract_t\">36</a>]: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Complete blood count with platelets and differential</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Blood smear</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Partial thromboplastin time (PTT)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hepatic and renal function tests</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cryoglobulins in patients with lesions and symptoms suggestive of this disorder (eg, acral lesions exacerbated by cold exposure) (see <a href=\"topic.htm?path=overview-of-cryoglobulins-and-cryoglobulinemia#H38\" class=\"medical medical_review\">&quot;Overview of cryoglobulins and cryoglobulinemia&quot;, section on 'Detection and analysis of cryoglobulins'</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Antineutrophil cytoplasmic antibodies (ANCA) </p><p/><p>The diagnostic utility of these laboratory studies is described in a table (<a href=\"image.htm?imageKey=DERM%2F62872\" class=\"graphic graphic_table graphicRef62872 \">table 2</a>). Additional tests may be ordered based upon the results of these studies, skin biopsy findings, and suspicion of the underlying disorder. In cases in which infection is suspected, blood, urine, <span class=\"nowrap\">and/or</span> tissue cultures should be obtained. Patients with inflammatory retiform purpura should be evaluated for the possibility of vasculitis. (See <a href=\"#H428237\" class=\"local\">'Lesion color and palpability'</a> above and <a href=\"topic.htm?path=evaluation-of-adults-with-cutaneous-lesions-of-vasculitis#H16172005\" class=\"medical medical_review\">&quot;Evaluation of adults with cutaneous lesions of vasculitis&quot;, section on 'Additional studies'</a>.)</p><p>The laboratory evaluation to confirm disseminated intravascular coagulation (DIC) in patients with purpura fulminans is discussed elsewhere. (See <a href=\"topic.htm?path=clinical-features-diagnosis-and-treatment-of-disseminated-intravascular-coagulation-in-adults#H12\" class=\"medical medical_review\">&quot;Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults&quot;, section on 'Diagnostic evaluation'</a> and <a href=\"topic.htm?path=disseminated-intravascular-coagulation-in-infants-and-children#H20\" class=\"medical medical_review\">&quot;Disseminated intravascular coagulation in infants and children&quot;, section on 'Diagnosis'</a>.)</p><p class=\"headingAnchor\" id=\"H8555553\"><span class=\"h1\">MANAGEMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The treatment of retiform purpura is dependent upon correction of the underlying etiology. (See <a href=\"#H425705\" class=\"local\">'Associated disorders'</a> above.)</p><p class=\"headingAnchor\" id=\"H12657719\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Retiform purpura are hemorrhagic skin lesions characterized by an angulated or branched appearance. The shape of retiform purpura is reflective of the pattern of the underlying vascular network. (See <a href=\"#H425698\" class=\"local\">'Etiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Retiform purpura occur as a consequence of disrupted vascular flow in the skin or subcutis. Disorders that cause vessel occlusion through thrombosis, intravascular protein deposition, emboli, or vessel wall destruction are associated with the development of these lesions. (See <a href=\"#H425698\" class=\"local\">'Etiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The acute appearance of extensive purpura, termed purpura fulminans, is a life-threatening disorder that occurs in the setting of disseminated intravascular coagulation (DIC). Identification of the underlying cause of DIC is essential for management. Retiform purpura may also occur in the setting of life-threatening opportunistic infections. (See <a href=\"#H136707379\" class=\"local\">'Life-threatening emergency (purpura fulminans)'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A thorough history and physical examination may provide valuable clues for diagnosis and should be performed in all patients who present with retiform purpura. The skin examination should include assessment of the color and distribution of purpura. (See <a href=\"#H425712\" class=\"local\">'Patient assessment'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Skin biopsies of retiform purpura can provide useful diagnostic information (<a href=\"image.htm?imageKey=DERM%2F77042\" class=\"graphic graphic_table graphicRef77042 \">table 1</a>). We perform a skin biopsy in almost all patients. A punch or excisional wedge biopsy should be performed to allow for adequate evaluation of vessels in the dermis and subcutis. Areas of necrosis should be avoided. A tissue culture should be performed if infection is suspected. (See <a href=\"#H426722\" class=\"local\">'Skin biopsy'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>An appropriate initial laboratory workup for stable patients with noninflammatory retiform purpura includes a complete blood count with differential and platelets, blood smear, partial thromboplastin time, hepatic and renal function tests, cryoglobulins in patients with acral lesions exacerbated by cold exposure, and antineutrophil cytoplasmic antibodies (ANCA) (<a href=\"image.htm?imageKey=DERM%2F62872\" class=\"graphic graphic_table graphicRef62872 \">table 2</a>). Additional tests may be added based upon these results, skin biopsy findings, and the likelihood of specific disorders. If infection is suspected, blood, tissue, <span class=\"nowrap\">and/or</span> tissue cultures should be performed. (See <a href=\"#H426729\" class=\"local\">'Laboratory tests'</a> above.) </p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/1\" class=\"nounderline abstract_t\">Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999; 341:586.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/2\" class=\"nounderline abstract_t\">Levi M. Current understanding of disseminated intravascular coagulation. Br J Haematol 2004; 124:567.</a></li><li class=\"breakAll\">Harris, EN. Antiphospholipid syndrome. In: Rheumatology, 2nd ed, Klippel, JH, Dieppe, PA (Eds), Mosby, London, UK 1998. p.7.35.1-7.35.6.</li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/4\" class=\"nounderline abstract_t\">Lim W, Crowther MA, Eikelboom JW. Management of antiphospholipid antibody syndrome: a systematic review. JAMA 2006; 295:1050.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/5\" class=\"nounderline abstract_t\">Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46:1019.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/6\" class=\"nounderline abstract_t\">Erkan D, Lockshin MD. New treatments for antiphospholipid syndrome. Rheum Dis Clin North Am 2006; 32:129.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/7\" class=\"nounderline abstract_t\">Lau DH, Wun T. Early manifestation of thrombotic thrombocytopenic purpura. Am J Med 1993; 95:544.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/8\" class=\"nounderline abstract_t\">Bouw MC, Dors N, van Ommen H, Ramakers-van Woerden NL. Thrombotic thrombocytopenic purpura in childhood. Pediatr Blood Cancer 2009; 53:537.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/9\" class=\"nounderline abstract_t\">Nazarian RM, Van Cott EM, Zembowicz A, Duncan LM. Warfarin-induced skin necrosis. J Am Acad Dermatol 2009; 61:325.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/10\" class=\"nounderline abstract_t\">Bauer KA. Coumarin-induced skin necrosis. Arch Dermatol 1993; 129:766.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/11\" class=\"nounderline abstract_t\">Bovill EG, Bauer KA, Dickerman JD, et al. The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood 1989; 73:712.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/12\" class=\"nounderline abstract_t\">Arepally G, Cines DB. Heparin-induced thrombocytopenia and thrombosis. Clin Rev Allergy Immunol 1998; 16:237.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/13\" class=\"nounderline abstract_t\">Warkentin TE. Heparin-induced thrombocytopenia: a ten-year retrospective. Annu Rev Med 1999; 50:129.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/14\" class=\"nounderline abstract_t\">Gorevic PD, Kassab HJ, Levo Y, et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 1980; 69:287.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/15\" class=\"nounderline abstract_t\">Li JY, Ivan D, Patel AB. Acral retiform purpura. Lancet 2017; 390:2382.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/16\" class=\"nounderline abstract_t\">Saadoun D, Elalamy I, Ghillani-Dalbin P, et al. Cryofibrinogenemia: new insights into clinical and pathogenic features. Am J Med 2009; 122:1128.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/17\" class=\"nounderline abstract_t\">Bloch KJ, Maki DG. Hyperviscosity syndromes associated with immunoglobulin abnormalities. Semin Hematol 1973; 10:113.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/18\" class=\"nounderline abstract_t\">Lane JE, Lane TN, Shams M, Lane CE. Cutaneous cholesterol embolization. J Am Acad Dermatol 2009; 60:711.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/19\" class=\"nounderline abstract_t\">Kusaba A, Imayama S, Furue M. Delayed appearance of livedo reticularis in 3 cases with a cholesterol embolism. Arch Dermatol 1999; 135:725.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/20\" class=\"nounderline abstract_t\">Aggarwal SK, Barik R, Sarma TC, et al. Clinical presentation and investigation findings in cardiac myxomas: new insights from the developing world. Am Heart J 2007; 154:1102.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/21\" class=\"nounderline abstract_t\">Pinede L, Duhaut P, Loire R. Clinical presentation of left atrial cardiac myxoma. A series of 112 consecutive cases. Medicine (Baltimore) 2001; 80:159.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/22\" class=\"nounderline abstract_t\">Callen JP. Cutaneous vasculitis: Relationship to systemic disease and therapy. Curr Probl Dermatol 1993; 5:50.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/23\" class=\"nounderline abstract_t\">Carlson JA, Cavaliere LF, Grant-Kels JM. Cutaneous vasculitis: diagnosis and management. Clin Dermatol 2006; 24:414.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/24\" class=\"nounderline abstract_t\">Carlson JA, Ng BT, Chen KR. Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis. Am J Dermatopathol 2005; 27:504.</a></li><li class=\"breakAll\">Della Rossa, A, Tavoni, et al. Cryoglobulinemia. In: Rheumatology, 3rd ed, Hochberg, M (Eds), Mosby, Philidelphia, PA 2003. p.1697-1703.</li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/26\" class=\"nounderline abstract_t\">Wilmer WA, Magro CM. Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment. Semin Dial 2002; 15:172.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/27\" class=\"nounderline abstract_t\">Kalajian AH, Malhotra PS, Callen JP, Parker LP. Calciphylaxis with normal renal and parathyroid function: not as rare as previously believed. Arch Dermatol 2009; 145:451.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/28\" class=\"nounderline abstract_t\">Bobrowski AE, Langman CB. Hyperoxaluria and systemic oxalosis: current therapy and future directions. Expert Opin Pharmacother 2006; 7:1887.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/29\" class=\"nounderline abstract_t\">Cochat P. Primary hyperoxaluria type 1. Kidney Int 1999; 55:2533.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/30\" class=\"nounderline abstract_t\">Jorizzo JL. Livedoid vasculopathy: what is it? Arch Dermatol 1998; 134:491.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/31\" class=\"nounderline abstract_t\">Bard JW, Winkelmann RK. Livedo vasculitis. Segmental hyalinizing vasculitis of the dermis. Arch Dermatol 1967; 96:489.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/32\" class=\"nounderline abstract_t\">Anavekar NS, Kelly R. Heterozygous prothrombin gene mutation associated with livedoid vasculopathy. Australas J Dermatol 2007; 48:120.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/33\" class=\"nounderline abstract_t\">Hurwitz RM, Haseman JH. The evolution of pyoderma gangrenosum. A clinicopathologic correlation. Am J Dermatopathol 1993; 15:28.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/34\" class=\"nounderline abstract_t\">Jorizzo JL, Solomon AR, Zanolli MD, Leshin B. Neutrophilic vascular reactions. J Am Acad Dermatol 1988; 19:983.</a></li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/35\" class=\"nounderline abstract_t\">Su WP, Davis MD, Weenig RH, et al. Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol 2004; 43:790.</a></li><li class=\"breakAll\">Piette W. Purpura: mechanisms and differential diagnosis. In: Dermatology, 2nd ed, Bolognia JL, Jorizzo JL, Rapini RP (Eds), Elsevier Limited, Spain 2008. Vol 1, p.321.</li><li><a href=\"https://www.uptodate.com/contents/approach-to-the-patient-with-retiform-angulated-purpura/abstract/37\" class=\"nounderline abstract_t\">Wysong A, Venkatesan P. An approach to the patient with retiform purpura. Dermatol Ther 2011; 24:151.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 16556 Version 8.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H12657719\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H429795\" id=\"outline-link-H429795\">INTRODUCTION</a></li><li><a href=\"#H425698\" id=\"outline-link-H425698\">ETIOLOGY</a><ul><li><a href=\"#H425705\" id=\"outline-link-H425705\">Associated disorders</a><ul><li><a href=\"#H933744\" id=\"outline-link-H933744\">- Intravascular abnormalities</a><ul><li><a href=\"#H933761\" id=\"outline-link-H933761\">Thrombotic and coagulopathic disorders</a></li><li><a href=\"#H933953\" id=\"outline-link-H933953\">Intravascular protein deposition</a></li><li><a href=\"#H933961\" id=\"outline-link-H933961\">Embolic disorders</a></li></ul></li><li><a href=\"#H933969\" id=\"outline-link-H933969\">- Vessel wall pathology</a></li><li><a href=\"#H8555196\" id=\"outline-link-H8555196\">- Other</a></li></ul></li></ul></li><li><a href=\"#H425712\" id=\"outline-link-H425712\">PATIENT ASSESSMENT</a><ul><li><a href=\"#H136707379\" id=\"outline-link-H136707379\">Life-threatening emergency (purpura fulminans)</a></li><li><a href=\"#H425719\" id=\"outline-link-H425719\">Patient history</a></li><li><a href=\"#H425726\" id=\"outline-link-H425726\">Physical examination</a><ul><li><a href=\"#H428237\" id=\"outline-link-H428237\">- Lesion color and palpability</a></li><li><a href=\"#H428245\" id=\"outline-link-H428245\">- Lesion distribution</a></li><li><a href=\"#H249255\" id=\"outline-link-H249255\">- Differential diagnosis</a></li><li><a href=\"#H428253\" id=\"outline-link-H428253\">- Associated physical findings</a></li></ul></li><li><a href=\"#H426722\" id=\"outline-link-H426722\">Skin biopsy</a><ul><li><a href=\"#H428261\" id=\"outline-link-H428261\">- Type and location of biopsy</a></li><li><a href=\"#H428268\" id=\"outline-link-H428268\">- Assessment of biopsy results</a></li></ul></li><li><a href=\"#H426729\" id=\"outline-link-H426729\">Laboratory tests</a></li></ul></li><li><a href=\"#H8555553\" id=\"outline-link-H8555553\">MANAGEMENT</a></li><li><a href=\"#H12657719\" id=\"outline-link-H12657719\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DERM/16556|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/53920\" class=\"graphic graphic_picture\">- Purpura fulminans</a></li><li><a href=\"image.htm?imageKey=DERM/61719\" class=\"graphic graphic_picture\">- Disseminated intravascular coagulation</a></li><li><a href=\"image.htm?imageKey=DERM/65011\" class=\"graphic graphic_picture\">- Antiphospholipid antibody syndrome - purpura</a></li><li><a href=\"image.htm?imageKey=DERM/79545\" class=\"graphic graphic_picture\">- Livedo reticularis - lower extremities</a></li><li><a href=\"image.htm?imageKey=DERM/61842\" class=\"graphic graphic_picture\">- Livedo reticularis - lower leg</a></li><li><a href=\"image.htm?imageKey=DERM/64023\" class=\"graphic graphic_picture\">- Livedo racemosa in polyarteritis nodosa</a></li><li><a href=\"image.htm?imageKey=DERM/74453\" class=\"graphic graphic_picture\">- Disseminated intravascular coagulation acral purpura</a></li><li><a href=\"image.htm?imageKey=DERM/65890\" class=\"graphic graphic_picture\">- Antiphospholipid antibody syndrome purpura</a></li><li><a href=\"image.htm?imageKey=DERM/51999\" class=\"graphic graphic_picture\">- Warfarin-induced skin necrosis on thighs</a></li><li><a href=\"image.htm?imageKey=DERM/62792\" class=\"graphic graphic_picture\">- Warfarin-induced skin necrosis on extremity</a></li><li><a href=\"image.htm?imageKey=HEME/80462\" class=\"graphic graphic_picture\">- Cutaneous necrosis warfarin</a></li><li><a href=\"image.htm?imageKey=DERM/63715\" class=\"graphic graphic_picture\">- Heparin necrosis ulcers</a></li><li><a href=\"image.htm?imageKey=DERM/71259\" class=\"graphic graphic_picture\">- Heparin necrosis purpura</a></li><li><a href=\"image.htm?imageKey=DERM/69150\" class=\"graphic graphic_picture\">- Cholesterol emboli retiform purpura</a></li><li><a href=\"image.htm?imageKey=DERM/53544\" class=\"graphic graphic_picture\">- Ecthyma gangrenosum purpura</a></li><li><a href=\"image.htm?imageKey=DERM/66308\" class=\"graphic graphic_picture\">- Calciphylaxis retiform purpura</a></li><li><a href=\"image.htm?imageKey=DERM/52262\" class=\"graphic graphic_picture\">- Livedoid vasculopathy - close view</a></li><li><a href=\"image.htm?imageKey=DERM/74436\" class=\"graphic graphic_picture\">- Cocaine purpura</a></li><li><a href=\"image.htm?imageKey=DERM/77067\" class=\"graphic graphic_picture\">- Cocaine purpura on ear</a></li><li><a href=\"image.htm?imageKey=DERM/55590\" class=\"graphic graphic_picture\">- Cocaine purpura on extremity</a></li><li><a href=\"image.htm?imageKey=DERM/57103\" class=\"graphic graphic_picture\">- Purpura fulminans large lesion</a></li><li><a href=\"image.htm?imageKey=ID/52107\" class=\"graphic graphic_picture\">- Acute meningococcemia</a></li><li><a href=\"image.htm?imageKey=DERM/76671\" class=\"graphic graphic_picture\">- Immune thrombocytopenia - ITP</a></li><li><a href=\"image.htm?imageKey=DERM/70793\" class=\"graphic graphic_picture\">- Multiple solar purpura</a></li><li><a href=\"image.htm?imageKey=ID/72076\" class=\"graphic graphic_picture\">- Splinter hemorrhages in infective endocarditis</a></li><li><a href=\"image.htm?imageKey=ID/68796\" class=\"graphic graphic_picture\">- Osler nodes in infective endocarditis</a></li><li><a href=\"image.htm?imageKey=ID/58380\" class=\"graphic graphic_picture\">- Janeway lesion in infective endocarditis</a></li></ul></li><li><div id=\"DERM/16556|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/77042\" class=\"graphic graphic_table\">- Retiform purpura histopathology</a></li><li><a href=\"image.htm?imageKey=DERM/62872\" class=\"graphic graphic_table\">- Screening tests for occlusive vascular syndromes</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acquired-ttp-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Acquired TTP: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=calciphylaxis-calcific-uremic-arteriolopathy\" class=\"medical medical_review\">Calciphylaxis (calcific uremic arteriolopathy)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cardiac-tumors\" class=\"medical medical_review\">Cardiac tumors</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-diagnosis-and-treatment-of-disseminated-intravascular-coagulation-in-adults\" class=\"medical medical_review\">Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-paroxysmal-nocturnal-hemoglobinuria\" class=\"medical medical_review\">Clinical manifestations and diagnosis of paroxysmal nocturnal hemoglobinuria</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-the-mixed-cryoglobulinemia-syndrome-essential-mixed-cryoglobulinemia\" class=\"medical medical_review\">Clinical manifestations and diagnosis of the mixed cryoglobulinemia syndrome (essential mixed cryoglobulinemia)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-evaluation-of-adults-with-suspected-native-valve-endocarditis\" class=\"medical medical_review\">Clinical manifestations and evaluation of adults with suspected native valve endocarditis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-of-antiphospholipid-syndrome\" class=\"medical medical_review\">Clinical manifestations of antiphospholipid syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-of-meningococcal-infection\" class=\"medical medical_review\">Clinical manifestations of meningococcal infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cryofibrinogenemia\" class=\"medical medical_review\">Cryofibrinogenemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-of-antiphospholipid-syndrome\" class=\"medical medical_review\">Diagnosis of antiphospholipid syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=disseminated-intravascular-coagulation-in-infants-and-children\" class=\"medical medical_review\">Disseminated intravascular coagulation in infants and children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=embolism-from-atherosclerotic-plaque-atheroembolism-cholesterol-crystal-embolism\" class=\"medical medical_review\">Embolism from atherosclerotic plaque: Atheroembolism (cholesterol crystal embolism)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-and-clinical-manifestations-of-invasive-aspergillosis\" class=\"medical medical_review\">Epidemiology and clinical manifestations of invasive aspergillosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-microbiology-clinical-manifestations-and-diagnosis-of-leprosy\" class=\"medical medical_review\">Epidemiology, microbiology, clinical manifestations, and diagnosis of leprosy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=evaluation-of-adults-with-cutaneous-lesions-of-vasculitis\" class=\"medical medical_review\">Evaluation of adults with cutaneous lesions of vasculitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=livedoid-vasculopathy\" class=\"medical medical_review\">Livedoid vasculopathy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-heparin-induced-thrombocytopenia\" class=\"medical medical_review\">Management of heparin-induced thrombocytopenia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=mucormycosis-zygomycosis\" class=\"medical medical_review\">Mucormycosis (zygomycosis)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-cryoglobulins-and-cryoglobulinemia\" class=\"medical medical_review\">Overview of cryoglobulins and cryoglobulinemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=primary-hyperoxaluria\" class=\"medical medical_review\">Primary hyperoxaluria</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=protein-c-deficiency\" class=\"medical medical_review\">Protein C deficiency</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pseudomonas-aeruginosa-bacteremia-and-endocarditis\" class=\"medical medical_review\">Pseudomonas aeruginosa bacteremia and endocarditis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pseudomonas-aeruginosa-skin-and-soft-tissue-infections\" class=\"medical medical_review\">Pseudomonas aeruginosa skin and soft tissue infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pyoderma-gangrenosum-pathogenesis-clinical-features-and-diagnosis\" class=\"medical medical_review\">Pyoderma gangrenosum: Pathogenesis, clinical features, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=strongyloidiasis\" class=\"medical medical_review\">Strongyloidiasis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-and-prognosis-of-paroxysmal-nocturnal-hemoglobinuria\" class=\"medical medical_review\">Treatment and prognosis of paroxysmal nocturnal hemoglobinuria</a></li></ul></div></div>","javascript":null}